Patent · US Active

Modulator

US8962032B2 · kind B2 · utility

0Cited by
5References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2010
Grant dateFeb 24, 2015
Priority date
Expiry dateDec 17, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/906
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided a method for suppressing a pro-inflammatory immune response in a cell, comprising providing to a cell sialic acid or analogs thereof, wherein the sialic acid or analogs are presented by a substrate such that a pro-inflammatory immune response in a cell is suppressed or an anti-inflammatory immune response is increased in a cell. Further, there is provided a method of treatment of inflammatory disease in a subject in need thereof. There is also provided a drug delivery device and a biomaterial which can modulate the inflammatory response in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.